Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients

@inproceedings{Kwon2017ComparisonOT,
  title={Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients},
  author={Ji-Soo Kwon and Taeeun Kim and Sun-Mi Kim and Heungsup Sung and Sung Shin and Young Hoon Kim and Eui-Cheol Shin and Sung-han Kim and Duck Jong Han},
  booktitle={Immune network},
  year={2017}
}
Cytomegalovirus (CMV) is one of the most important opportunistic infections in transplant recipients. Tests for CMV-specific T cell responses have been proposed to change the current risk stratification strategy using CMV assays. We evaluated the usefulness of pre-transplant CMV-specific T cell assays in kidney transplant (KT) candidates for predicting the… CONTINUE READING